CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 117 filers reported holding CUREVAC N V in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $516,048 | -44.2% | 75,556 | -14.9% | 0.00% | – |
Q2 2023 | $924,838 | -21.1% | 88,756 | -47.3% | 0.00% | – |
Q1 2023 | $1,172,829 | +125.4% | 168,268 | +95.0% | 0.00% | – |
Q4 2022 | $520,413 | +9.6% | 86,304 | +43.4% | 0.00% | – |
Q3 2022 | $475,000 | +17.9% | 60,201 | +102.9% | 0.00% | – |
Q2 2022 | $403,000 | +17.8% | 29,676 | +70.2% | 0.00% | – |
Q1 2022 | $342,000 | -42.5% | 17,437 | +0.6% | 0.00% | – |
Q4 2021 | $595,000 | -30.5% | 17,334 | +10.5% | 0.00% | – |
Q3 2021 | $856,000 | -95.1% | 15,688 | -93.3% | 0.00% | -100.0% |
Q2 2021 | $17,325,000 | +4659.6% | 235,775 | +5816.6% | 0.01% | – |
Q1 2021 | $364,000 | +26.4% | 3,985 | +11.9% | 0.00% | – |
Q4 2020 | $288,000 | +405.3% | 3,561 | +193.1% | 0.00% | – |
Q3 2020 | $57,000 | – | 1,215 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |